488 related articles for article (PubMed ID: 19111590)
1. Recombinant Mycobacterium smegmatis mc(2)155 vaccine expressing outer membrane protein 26 kDa antigen affords therapeutic protection against Helicobacter pylori infection.
Lü L; Cao HD; Zeng HQ; Wang PL; Wang LJ; Liu SN; Xiang TX
Vaccine; 2009 Feb; 27(7):972-8. PubMed ID: 19111590
[TBL] [Abstract][Full Text] [Related]
2. Oral immunization with recombinant Mycobacterium smegmatis expressing the outer membrane protein 26-kilodalton antigen confers prophylactic protection against Helicobacter pylori infection.
Lü L; Zeng HQ; Wang PL; Shen W; Xiang TX; Mei ZC
Clin Vaccine Immunol; 2011 Nov; 18(11):1957-61. PubMed ID: 21900527
[TBL] [Abstract][Full Text] [Related]
3. Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses.
Nyström J; Svennerholm AM
Vaccine; 2007 Mar; 25(14):2591-8. PubMed ID: 17239498
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model.
Liu KY; Shi Y; Luo P; Yu S; Chen L; Zhao Z; Mao XH; Guo G; Wu C; Zou QM
Vaccine; 2011 Sep; 29(38):6679-85. PubMed ID: 21745524
[TBL] [Abstract][Full Text] [Related]
5. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori bacterial ghost containing recombinant Omp18 as a putative vaccine.
Talebkhan Y; Bababeik M; Esmaeili M; Oghalaei A; Saberi S; Karimi Z; Afkhami N; Mohammadi M
J Microbiol Methods; 2010 Sep; 82(3):334-7. PubMed ID: 20621134
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen.
Inoue K; Shiota S; Yamada K; Gotoh K; Suganuma M; Fujioka T; Ahmed K; Iha H; Nishizono A
Helicobacter; 2009 Oct; 14(5):135-43. PubMed ID: 19751439
[TBL] [Abstract][Full Text] [Related]
8. Oral immunization of mice with attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.
Liu X; Hu J; Zhang X; Fan D
Chin Med J (Engl); 2002 Oct; 115(10):1513-6. PubMed ID: 12490099
[TBL] [Abstract][Full Text] [Related]
9. Oral vaccination with liposome-encapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against H. pylori infection in BALB/c mice.
Zhao W; Wu W; Xu X
Vaccine; 2007 Nov; 25(44):7664-73. PubMed ID: 17913305
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background.
Sutton P; Doidge C; Pinczower G; Wilson J; Harbour S; Swierczak A; Lee A
FEMS Immunol Med Microbiol; 2007 Jul; 50(2):213-9. PubMed ID: 17567282
[TBL] [Abstract][Full Text] [Related]
11. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
Li X; Xing Y; Guo L; Lv X; Song H; Xi T
Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
[TBL] [Abstract][Full Text] [Related]
12. Immunological features and efficacy of the reconstructed epitope vaccine CtUBE against Helicobacter pylori infection in BALB/c mice model.
Guo L; Liu K; Zhao W; Li X; Li T; Tang F; Zhang R; Wu W; Xi T
Appl Microbiol Biotechnol; 2013 Mar; 97(6):2367-78. PubMed ID: 23064457
[TBL] [Abstract][Full Text] [Related]
13. Systemic immunization with unadjuvanted whole Helicobacter pylori protects mice against heterologous challenge.
Harbour SN; Every AL; Edwards S; Sutton P
Helicobacter; 2008 Dec; 13(6):494-9. PubMed ID: 19166414
[TBL] [Abstract][Full Text] [Related]
14. A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori.
Flach CF; Svensson N; Blomquist M; Ekman A; Raghavan S; Holmgren J
Vaccine; 2011 Feb; 29(6):1235-41. PubMed ID: 21147129
[TBL] [Abstract][Full Text] [Related]
15. [Construction of attenuated Salmonella typhimurium vaccine strain expressing Helicobacter pylori catalase and observation on its protective immunity].
Liao W; Chen M; Zhu S
Zhonghua Yi Xue Za Zhi; 2001 May; 81(10):613-6. PubMed ID: 11798935
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic and therapeutic efficacy of the epitope vaccine CTB-UA against Helicobacter pylori infection in a BALB/c mice model.
Guo L; Liu K; Xu G; Li X; Tu J; Tang F; Xing Y; Xi T
Appl Microbiol Biotechnol; 2012 Sep; 95(6):1437-44. PubMed ID: 22569640
[TBL] [Abstract][Full Text] [Related]
17. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization.
Akhiani AA; Stensson A; Schön K; Lycke N
Scand J Immunol; 2006 Feb; 63(2):97-105. PubMed ID: 16476008
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic vaccination with Salmonella-delivered codon-optimized outer inflammatory protein DNA vaccine enhances protection in Helicobacter pylori infected mice.
Chen J; Lin M; Li N; Lin L; She F
Vaccine; 2012 Aug; 30(36):5310-5. PubMed ID: 22749593
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of a DNA vaccine based on Helicobacter pylori urease B: failure to prevent experimental infection in the mouse model.
Zavala-Spinetti L; Breslin MB; Correa H; Bégué RE
Helicobacter; 2006 Dec; 11(6):517-22. PubMed ID: 17083372
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of vaccination with DNA of the H. Pylori genomic library in experimentally infected mice.
Dzwonek A; Mikula M; Woszczyński M; Hennig E; Ostrowski J
Cell Mol Biol Lett; 2004; 9(3):483-95. PubMed ID: 15332125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
